UBS Group Analysts Give Evonik Industries (EVK) a €27.00 Price Target

Evonik Industries (FRA:EVK) received a €27.00 ($32.14) price objective from equities research analysts at UBS Group in a report issued on Monday, www.boersen-zeitung.de reports. The firm currently has a “sell” rating on the stock. UBS Group’s price objective indicates a potential downside of 16.82% from the stock’s current price.

A number of other analysts have also recently commented on EVK. Credit Suisse Group set a €34.30 ($40.83) price target on Evonik Industries and gave the stock a “buy” rating in a research report on Tuesday, September 26th. Deutsche Bank set a €32.00 ($38.10) price target on Evonik Industries and gave the stock a “neutral” rating in a research report on Thursday, September 28th. Baader Bank set a €38.00 ($45.24) price target on Evonik Industries and gave the stock a “buy” rating in a research report on Thursday, September 28th. Barclays set a €34.50 ($41.07) price target on Evonik Industries and gave the stock a “buy” rating in a research report on Friday, September 29th. Finally, DZ Bank reaffirmed a “neutral” rating on shares of Evonik Industries in a research report on Monday, October 2nd. Three research analysts have rated the stock with a sell rating, six have given a hold rating and eleven have issued a buy rating to the company’s stock. Evonik Industries has a consensus rating of “Hold” and a consensus price target of €33.87 ($40.32).

Shares of Evonik Industries (FRA:EVK) traded up €0.48 ($0.57) on Monday, reaching €32.46 ($38.64). The company’s stock had a trading volume of 1,152 shares. Evonik Industries has a 12 month low of €26.78 ($31.88) and a 12 month high of €32.97 ($39.25). The firm has a market cap of $15,100.00 and a PE ratio of 20.68.

COPYRIGHT VIOLATION NOTICE: “UBS Group Analysts Give Evonik Industries (EVK) a €27.00 Price Target” was originally published by American Banking News and is owned by of American Banking News. If you are accessing this report on another publication, it was illegally stolen and republished in violation of United States and international trademark and copyright legislation. The correct version of this report can be viewed at https://www.americanbankingnews.com/2018/01/22/ubs-group-analysts-give-evonik-industries-evk-a-27-00-price-target.html.

About Evonik Industries

Evonik Industries AG engages in the specialty chemicals business worldwide. It operates through Nutrition & Care, Resource Efficiency, Performance Materials, and Services segments. The Nutrition & Care segment offers specialty chemicals, including amphoteric surfactants, ceramides, phytosphingosines, oleochemical quaternary derivatives, organically modified silicones, superabsorbents, amino acids and amino acid derivatives, synthesis products, pharmaceutical polymers, and DL-methionine for use in consumer goods, animal nutrition, and healthcare sectors.

Analyst Recommendations for Evonik Industries (FRA:EVK)

Receive News & Ratings for Evonik Industries Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Evonik Industries and related companies with MarketBeat.com's FREE daily email newsletter.

Leave a Reply